Just days after finalizing a monumental $10.6 billion acquisition of Nuvalent, a move that significantly bolsters its oncology pipeline, GlaxoSmithKline…
Read More
Novo Nordisk’s Wegovy Pill Gains UK Approval Amidst Growing Demand and Competitive Landscape
The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for Novo Nordisk’s oral semaglutide medication, marketed…
Read More
Tavapadon Poised for Competitive Parkinson’s Disease Market Following Promising Tremor Data
AbbVie’s tavapadon, an investigational oral once-daily dopamine D1/D5 partial agonist, is nearing a potential regulatory submission, bolstered by new post-hoc…
Read MoreYOU MAY HAVE MISSED
